Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients

Atherosclerosis

Volumn 138, Issue 1, 1998, Pages 25-34

  Von Eckardstein, Arnold ^a   Huang, Yadong ^a,g   Kastelein, John J P ^b   Geisel, Jürgen ^c   Real, José T ^d   Kuivenhoven, Jan Albert ^b   Miccoli, Roberto ^e   Noseda, Giorgio ^f   Assmann, Gerd ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c SAARLAND UNIVERSITY   (Germany)

^d UNIVERSITY OF VALENCIA   (Spain)

^e UNIVERSITY OF PISA   (Italy)

^f Ospedale Beata Vergine   (Switzerland)

^g GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

Familial HDL deficiency; HDL subclasses; Phospholipid transfer

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; TANGIER DISEASE;

EID: 17744414890     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00280-3     Document Type: Article

References (45)

1. Fredrickson D.S., Altrocchi P.H., Avioli L.V., Goodman D.S., Goodman H.C. Tangier disease - combined clinical staff conference at the National Institutes of Health. Ann Intern Med. 55:1961;1016-1021.
2. Assmann G, von Eckardstein A, Brewer HB Jr. Familial HDL deficiency. Tangier disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Basis of Inherited Disease, 7th ed. New York: McGraw-Hill, 1995:2053-72.
3. Von Eckardstein A., Huang Y., Wu S. No, Funke H., Noseda G., Assmann G. Reverse cholesterol transport in plasmas of patients with different forms of familial high density lipoprotein deficiency. Arterioscler Thromb Vasc Biol. 15:1995;691-703.
4. Fielding C., Fielding P.E. Molecular physiology of reverse cholesterol transport. J Lipid Res. 36:1995;211-228.
5. Von Eckardstein A., Huang Y., Assmann G. Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr Opin Lipidol. 5:1994;404-416.
6. Barrans A., Jaspard B., Barbaras R., Chap H., Perret B., Collet X. Pre-β HDL: structure and metabolism. Biochim Biophys Acta. 1300:1996;73-83.
7. Castro G.R., Fielding C.J. Early incorporation of cell-derived cholesterol into pre-β-migrating high density lipoprotein. Biochemistry. 27:1988;25-29.
8. Huang Y., von Eckardstein A., Assmann G. Cell-derived cholesterol cycles between different HDLs and LDL for its effective esterification in plasma. Arterioscler Thromb. 13:1993;445-458.
9. Miida T., Kawano M., Fielding C.J., Fielding P.E. Regulation of the concentration of preβ high density lipoprotein in normal plasma by cell membranes and lecithin:cholesterol acyltransferase. Biochemistry. 31:1992;11112-11117.
10. von Eckardstein A., Jauhiainen M., Huang Y., Metso J., Langer C., Pussinen P., Wu S., Ehnholm C., Assmann G. Phospholipid transfer protein mediated conversion of high density lipoproteins (HDL) generates preβ1-HDL. Biochim Biophys Acta. 1301:1996;255-261.
11. Huang Y., von Eckardstein A., Wu S., Assmann G. Generation oif preβ1-high density lipoprotein (HDL) and conversion into α-HDL: evidence for disturbed preβ1-HDL conversion in Tangier disease. Arterioscler Thromb Vasc Biol. 15:1995;1746-1754.
12. Jaspard B., Collet X., Barbaras R., Manent J., Vieu C., Pontonnier G., Chap H., Perret B. Biochemical characterization of preβ1- high-density lipoprotein from human ovarian follicular fluid: evidence for the presence of a lipid core. Biochemistry. 35:1996;1352-1357.
13. Assmann G., Smootz E., Adler K., Capurso A., Oette K. The lipoprotein abnormality in Tangier disease. Quantitation of A apoproteins. J Clin Invest. 59:1977;565-575.
14. Gibbels E., Schaefer H.E., Runne U., Schröder J.M., Haupt W.F., Assmann G. Severe polyneuropathy in Tangier disease mimicking syringomyelia or leprosy. Clinical, biochemical, electrophysiological, and morphological evaluation, including electron microscopy of nerve, muscle, and skin biopsies. J Neurol. 232:1985;283-290.
15. Roemling R., von Eckardstein A., Funke H., Motti C., Fragiacomo G., Noseda G., Assmann G. A nonsense mutation in the apolipoprotein A-I gene is associated with high density lipoprotein deficiency but not with coronary heart disease. Arterioscler Thromb. 14:1994;1915-1922.
16. Navalesi R., Miccoli R., Odoguardi L., Funke H., von Eckardstein A., Wiebusch H., Assmann G. Genetically determined absence of HDL-cholesterol and coronary atherosclerosis (letter). Lancet. 346:1995;708-709.
17. Miccoli R., Bertolotto A., Navalesi R., Odoguardi L., Boni A., Wessling J., Funke H., Wiebusch H., von Eckardstein A., Assmann G. Hemizygosity for a structural apolipoprotein A-I-variant - ApoA-I(L141R)Pisa - causes high density lipoprotein deficiency, corneal opacifications, and coronary heart disease. Circulation. 94:1996;1622-1628.
18. Kastelein J.J.P., Pritchard H.P., Erkelens D.W., Kuivenhoven J.A., Albers J.J., Frohlich J.J. Familial high density lipoprotein (HDL) deficiency in a family of Duth descent. J Intern Med. 231:1991;413-419.
19. Funke H., von Eckardstein A., Pritchard P.H., Kastelein J.J.P., Droste C., Albers J.J., Assmann G. A molecular defect causing fish eye disease: an amino acid exchange in lecithin:cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity. Proc Natl Acad Sci USA. 88:1991;4855-4859.
20. Kuivenhoven J.A., Stalenhoef A.F.H., Hill J.S., Demacker P.N.M., Errami A., Kastelein J.J.P., Pritchard P.H. Two novel molecular defects in the LCAT gene are asociated with fish-eye disease. Arterioscler Thromb Vasc Biol. 16:1996;294-303.
21. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 34:1955;1345-1353.
22. von Eckardstein A., Funke H., Chirazi A., Chen-Haudenschild C., Schulte H., Schönfeld R., Köhler E., Schwarz S., Steinmetz A., Assmann G. Gender-specific effects of the glutamine/histidine polymorphism in apolipoprotein A-IV on high density lipoprotein metabolism. Arterioscler Thromb. 14:1994;1114-1120.
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
24. Pritchard P.H., McLeod R., Frohlich J., Park M.C., Kudchodkar B.J., Lacko A.G. Lecithin:cholesterol acyltransferase in familial HDL-deficiency. Biochim Biophys Acta. 958:1988;227-234.
25. Kato H., Nakanishi T., Arai H. Purification, microheterogeneity, and stability of human lipid transfer protein. J Biol Chem. 264:1989;4082-4087.
26. Nakanishi T., Tahara D., Akazawa S., Miyake S., Nagataki S. Plasma lipid transfer activities in hyper-high density lipoprotein cholesterolemic and healthy control subjects. Metabolism. 39:1990;225-230.
27. Jauhiainen M., Metso J., Pahlman R., Blomqvist S., van Tol A., Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem. 268:1993;4032-4036.
28. Clay M.A., Barter P.J. Formation of new HDL particles from lipid-free apolipoprotein A-I. J Lipid Res. 37:1996;1722-1732.
29. Musliner T.A., Long D.L., Forte T.M., Nichols A.V., Gong E.L., Blanche, Krauss R.M. Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I. J Lipid Res. 32:1991;917-932.
30. Clay M.A., Newnham H.H., Forte T.M., Barter P.J. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apoA-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta. 1124:1992;52-58.
31. Kunitake S.T., Mendel C.M., Hennessy L.K. Interconversion between apolipoproteins of pre-beta and alpha electrophoretic mobilities. J Lipid Res. 33:1992;1807-1816.
32. Ishida B.Y., Albee D., Paigen B. Interconversion of prebeta migrating lipoproteins containing apoA-I and HDL. J Lipid Res. 31:1990;227-236.
33. Neary R., Bhatnagar D., Durrington P., Ishola M., Arrol S., Mackness M. An investigation of the role of lecithin:cholesterol acyltransferase.and triglyceride-rich lipoproteins in the metabolism of high density lipoproteins. Atherosclerosis. 89:1991;35-48.
34. Luna-Chavez C., Gong E.L., Forte T.M., Nichols A.V. Sodium oleate facilitated reassembly of apolipoprotein with phosphatidylcholine. Biochim Biophys Acta. 1215:1994;141-149.
35. Sparks D.L., Davidson W.S., Lund-Katz S., Phillips M.C. Effect of cholesterol on the charge and structure of apolipoprotein A-I in high density lipoprotein particles. J Biol Chem. 268:1993;23250-23257.
36. Davidson W.S., Sparks D.L., Lund-Katz S., Philips M.C. The molecular basis for the difference of charge between preβ- and α-migrating high density lipoproteins. J Biol Chem. 269:1994;8959-8965.
37. Liang H.-Q., Rye K.-A., Barter P.J. Remodelling of reconstituted high density lipoproteins by lecithin:cholesterol acyltransferase. J Lipid Res. 37:1996;1962-1970.
38. Hennessy L.K., Kunitake S.T., Kane J.P. Apolipoprotein A-I-containing lipoproteins, with or without apolipoprotein A-II, as progenitors of preβ-high density lipoprotein particles. Biochemistry. 32:1993;5759-5765.
39. Liang H.-Q., Rye K.-A., Barter P.J. Dissociation of lipid-free apolipoprotein A-I from high density lipopioteins. J Lipid Res. 35:1994;1187-1199.
40. Liang H.-Q., Rye K.-A., Barter P.J. Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools. Biochim Biophys Acta. 1257:1995;31-37.
41. Francone O.L., Royer L., Haghpassand M. Increased preβ-HDL levels, cholesterol efflux, and LCAT mediated esterifcation in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes. J Lipid Res. 37:1996;1268-1277.
42. Jiang X.-J., Francone O.L., Bruce C., Milne R., Mar J., Walsh A., Breslow J.L., Tall A.R. Increased preβ-high density lipoprotein, aplipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J Clin Invest. 98:1996;2373-2380.
43. Brinton E.A., Eisenberg S., Breslow J.L. Human HDL-cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL size. Arterioscler Thromb Vasc Biol. 14:1994;707-720.
44. De Buyzere M., Delanghe J., Labeur C., Noens L., Benoit Y., Baert J., Rosseneu M. Acquired hypoalphalipoproteinemia. Clin Chem. 38:1992;776-781.
45. Emmerich J., Verges B., Tauveron I., Rader D., Santamarina-Fojo S., Schaefer J., Ayrault-Jarrier M., Thieblot P., Brewer H.B. Jr. Familial HDL deficiency due to marked hypercatabolism of normal apoA-I. Arterioscler Thromb. 13:1993;1299-1306.